Polycythemia Vera

Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to Polycythemia Vera: Polycythemia rubra vera

polycythemia vera

[‚päl·i‚sī′thē·mē·ə ′vir·ə]
An absolute increase in all blood cells derived from bone marrow, especially erythrocytes.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Polycythemia Vera


(also erythremia, Vaquez’ disease), a chronic disease of the hematopoietic system first described by the French physician L. H. Vaquez in 1892. Polycythemia vera is characterized by an increase in erythrocyte, leukocyte, and platelet mass and in plasma volume. It is classified as a form of leukemia. The course of the disease is comparatively benign. The principal symptoms are a dark red coloration of the skin, elevated blood pressure, proneness to hemorrhaging and thrombosis, and enlargement of the spleen.

Cytological analysis of bone marrow is an important aid in diagnosis. Treatment includes phlebotomy and the administration of cytostatics.


Vorob’ev, A. I., M. D. Brilliant. Patogenez i terapiia leikozov. Moscow, 1976.
The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Polycythemia Vera. Curr Treat Options Oncol 2018; 19(2):12(2):12.
Polycythemia vera (PV) is a myeloproliferative disorder with an increased risk of both arterial and venous thromboembolism including acute myocardial infarction through increased risk for clot formation [5].
Pereira et al., "Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera," European Journal of Haematology, vol.
A 55-year-old woman had been diagnosed as having polycythemia vera in 2005 and followed up by a hematologist at another hospital.
(2.) Scott LM, TongW, Levine RL, etal.JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
from CHOP, along with Rivella and colleagues, investigated in the current study how minihepcidins affected beta-thalassemia and polycythemia vera (PV) in mice separately engineered to model each human disease.
Treatment of polycythemia vera: use of 32P alone or with a maintenance therapy using Hydroxyurea in 461 patients aged more than 65 years.
As model genes, the researchers used JAK2, a gene that when mutated causes a bone marrow disorder known as polycythemia vera; SERP1NA1, a gene that when mutated causes alpha 1-antitrypsin deficiency, an inherited disorder that may cause lung and liver disease; and AAVS1, a gene that's been recently discovered to be a "safe harbor" in the human genome for inserting foreign genes.
A JAK2 mutation also shows up in people with polycythemia vera, a disease marked by a high red blood cell count.
Nine of these 13 cases had a prothrombotic state like myeloproliferative disorder, Polycythemia vera, protein C and protein S deficiency.
As for his polycythemia, the V617F mutation in the JAK2 gene was negative and therefore polycythemia vera was ruled out.
Increased [Hb] may indicate erythrocytosis due to smoking (7) or in response to hypoxia at high altitudes (8), polycythemia vera (9), congenital heart disease (10), severe chronic obstructive pulmonary disease (11), or severe dehydration (12).